From the genetics of ankylosing spondylitis to new biology and drug target discovery
Genome-wide association studies (GWAS) have identified 113 single nucleotide polymorphisms (SNPs) affecting the risk of developing ankylosing spondylitis (AS), and an on-going GWAS study will likely identify 100+ new risk loci. The translation of genetic findings to novel disease biology and treatme...
Hlavní autoři: | Zaarour, N, Li, Y, Shi, H, Bowness, P, Chen, L |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Frontiers Media
2021
|
Podobné jednotky
-
OVERVIEW OF ANKYLOSING SPONDYLITIS GENETICS AND PATHOGENESIS
Autor: Bowness, P
Vydáno: (2012) -
GM-CSF primes proinflammatory monocyte responses in Ankylosing Spondylitis
Autor: Shi, H, a další
Vydáno: (2020) -
The immunology of Ankylosing Spondylitis
Autor: Bowness, P
Vydáno: (2011) -
New developments in our understanding of Ankylosing Spondylitis pathogenesis
Autor: Voruganti, A, a další
Vydáno: (2020) -
Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.
Autor: Fischer, R, a další
Vydáno: (2012)